computer-aided drug design software (Glaxo Smith)
90
Structured Review
Glaxo Smith
computer-aided drug design software
Computer Aided Drug Design Software, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-aided+drug+design+software/computer+software/pm17013809-624-28-11
Average 90 stars, based on 1 article reviews
Computer Aided Drug Design Software, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-aided+drug+design+software/computer+software/pm17013809-624-28-11
Average 90 stars, based on 1 article reviews
computer-aided drug design software - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Drug discovery:Article Title: The evolution of progesterone receptor ligands. Article Snippet: Progesterone is one of the first nuclear receptor hormones to be described functionally and subsequently approached as a drug target.. Because progesterone (1) affects both menstruation and gestation via the progesterone receptor (PR), research aimed at modulating its activity is usually surrounded by controversy.. However, ligands for PR were developed into drugs, and their evolution can be crudely divided into three periods: (1) drug-like steroids thatmimic the gestational properties of progesterone; (2) drug-like steroids with different properties from progesterone and expanded therapeutic applications; and (3) non-steroidal PR ligands with improved selectivity and modulator properties and further expanded therapeutic applications. Software:Article Title: The evolution of progesterone receptor ligands. Article Snippet: Progesterone is one of the first nuclear receptor hormones to be described functionally and subsequently approached as a drug target.. Because progesterone (1) affects both menstruation and gestation via the progesterone receptor (PR), research aimed at modulating its activity is usually surrounded by controversy.. However, ligands for PR were developed into drugs, and their evolution can be crudely divided into three periods: (1) drug-like steroids thatmimic the gestational properties of progesterone; (2) drug-like steroids with different properties from progesterone and expanded therapeutic applications; and (3) non-steroidal PR ligands with improved selectivity and modulator properties and further expanded therapeutic applications. |